Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fast and Easy Test Could Revolutionize Blood Transfusions

By LabMedica International staff writers
Posted on 27 Jan 2026

Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. More...

Although blood units have a fixed expiration date, cells from different donors age at different rates, which can affect how well transfusions work, especially in vulnerable patients. Researchers have now developed a fast, chip-based test that can rapidly evaluate red blood cell quality after storage, offering a potential new tool to better manage blood supplies.

The test, developed through a collaboration between the University of Colorado Boulder (Boulder, CO, USA) and the University of Colorado Anschutz (Aurora, CO), fits on a single microchip and is designed to deliver results in about two minutes. The device, called a surface acoustic wave hemolysis assay, uses vibrations generated on a lithium niobate wafer to mechanically stress red blood cells. As the cells heat up and rupture, the system captures information that reflects membrane strength and overall cell health.

In laboratory tests using donor red blood cells, the researchers observed that some samples hemolyzed at lower temperatures than others. These samples also showed distinct metabolite patterns previously linked to aging red blood cells. The findings, published in Lab on a Chip, suggest that older or more fragile cells break down faster under acoustic stress, making the method a potential indicator of blood quality after storage.

If validated further, the chip-based test could help blood centers allocate higher-quality units to patients who need them most, such as children or individuals with conditions like sickle cell disease who require frequent transfusions. It may also reduce waste by improving decision-making around stored blood. In addition to transfusion medicine, the researchers believe similar lab-on-a-chip systems could be adapted to screen for blood-related diseases or monitor protein and metabolite changes linked to various health conditions.

“Our vision is to have a chip the size of a dime that you can plug into your cell phone,” said Associate Professor Xiaoyun Ding, senior author of the study. “It could use your phone’s camera and an app to read out the results in just two minutes.”

Related Links:
University of Colorado Boulder
University of Colorado Anschutz


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.